Quantitative Investment Management, LLC Alnylam Pharmaceuticals, Inc. Transaction History

Quantitative Investment Management, LLC

$1.02 Billion
Q3 2024

A detailed history of Quantitative Investment Management, LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Quantitative Investment Management, LLC holds 802 shares of ALNY stock, worth $203,186. This represents 0.02% of its overall portfolio holdings.

Number of Shares

802

Previous 9,336 91.41%

Holding current value

$203,186

Previous $2.27 Million 90.3%

% of portfolio

0.02%

Previous 0.25%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$233.81 - $287.01 $2 Million - $2.45 Million	-8,534 Reduced 91.41%	802 $220,000
Q2 2024 Aug 14, 2024	BUY	$143.31 - $247.0 $840,799 - $1.45 Million	5,867 Added 169.13%	9,336 $2.27 Million
Q1 2024 May 15, 2024	BUY	$146.51 - $198.2 $508,243 - $687,555	3,469 New	3,469 $518,000
Q4 2021 Feb 14, 2022	SELL	$159.56 - $209.29 $2.28 Million - $2.99 Million	-14,293 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$169.75 - $207.73 $1.53 Million - $1.88 Million	-9,032 Reduced 38.72%	14,293 $2.7 Million
Q2 2021 Aug 16, 2021	BUY	$128.63 - $176.89 $961,380 - $1.32 Million	7,474 Added 47.15%	23,325 $3.95 Million
Q1 2021 May 17, 2021	BUY	$126.83 - $175.69 $1.27 Million - $1.75 Million	9,979 Added 169.94%	15,851 $2.24 Million
Q4 2020 Feb 16, 2021	BUY	$122.97 - $147.0 $722,079 - $863,184	5,872 New	5,872 $763,000
Q3 2020 Nov 13, 2020	SELL	$121.19 - $165.49 $4.96 Million - $6.78 Million	-40,945 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$104.21 - $156.44 $2.11 Million - $3.16 Million	20,207 Added 97.44%	40,945 $6.06 Million
Q1 2020 May 15, 2020	SELL	$93.12 - $133.99 $10.2 Million - $14.7 Million	-110,054 Reduced 84.14%	20,738 $2.26 Million
Q4 2019 Feb 14, 2020	BUY	$74.51 - $124.23 $4.68 Million - $7.8 Million	62,784 Added 92.32%	130,792 $15.1 Million
Q3 2019 Nov 14, 2019	BUY	$70.9 - $87.82 $4.82 Million - $5.97 Million	68,008 New	68,008 $5.47 Million
Q2 2019 Aug 14, 2019	SELL	$65.86 - $92.79 $790,320 - $1.11 Million	-12,000 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$72.76 - $93.45 $574,804 - $738,255	-7,900 Reduced 39.7%	12,000 $1.12 Million
Q4 2018 Feb 12, 2019	BUY	$62.67 - $88.33 $1.25 Million - $1.76 Million	19,900 New	19,900 $1.45 Million
Q2 2018 Aug 10, 2018	SELL	$88.31 - $107.8 $5.1 Million - $6.23 Million	-57,800 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$115.92 - $148.54 $6.25 Million - $8.01 Million	53,900 Added 1382.05%	57,800 $6.88 Million
Q4 2017 Feb 14, 2018	SELL	$114.49 - $139.98 $114,490 - $139,980	-1,000 Reduced 20.41%	3,900 $495,000
Q3 2017 Nov 13, 2017	BUY	$72.53 - $118.27 $355,397 - $579,523	4,900	4,900 $575,000

Others Institutions Holding ALNY

# of Institutions

644

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.2B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantitative Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantitative Investment Management, LLC with notifications on news.

Account

Quantitative Investment Management, LLC Alnylam Pharmaceuticals, Inc. Transaction History